Cns Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-05-30
Clinical Trial Update: Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma [Phase 1]
A Phase 1 clinical trial from University College London evaluating CD19-directed CAR T-cell therapy for relapsed/refractory Primary CNS Lymp…